Withania somnifera (L) Dunal, commonly known as ashwagandha or Indian ginseng, is the source of large number of pharmacologically active withanolides. Withaferin-A (WS-3), a major withanolide of W. somnifera, has been proven to be an effective anti-cancer molecule. In this study, a liquid culture system for shoot proliferation, biomass accumulation and withaferin-A production of an elite accession (AGB002) of W. somnifera was investigated. The nodal explants cultured on Murashige and Skoog (MS) semi-solid medium supplemented with various concentrations of 6-benzyl adenine (BA) and Kinetin (Kn) 2 elicited varied responses. The highest number of regenerated shoots per ex-plant (35±3.25) and the maximum average shoot length (5.0± 0.25 cm) were recorded on MS medium supplemented with BA (5.0 μM). The shoots were further proliferated in half and full strength MS liquid medium supplemented with the same concentration BA. It was interesting to note that shoots cultured on MS half strength liquid medium fortified with 4 gL-1 FW (fresh weight) shoot inoculum mass derived from 5 week old nodal explants of W. somnifera showed highest accumulation of biomass and withaferin A content in 5 weeks.Withaferin A was produced in relatively high amounts The production of Withania drugs in India has been esti-mated about 9,127-tonnes per year far exceeding the annual plant production of 5,905-tonnes (Sivanandhan et al. 2012). Presently, whole plants are being harvested from wild for the production of Withania-based medicines to meet a growing demand of pharmaceutical industries. This random harvesting of ashwagandha germplasm for withanolide production is economically and environmentally unwise as it causes loss of genetic diversity and habitat destruction. An elegant alter-native to these apparent hurdles would be to identify the genotype rich in bioactive withanolides, develop high yielding in vitro production methods and to and improve them genetically for cultivation to meet the demand of bioactive withanolides.Plant cell and organ cultures offer an excellent opportunity for homogenous, controlled production of metabolites, throughout the year, especially when we take commercial demand into account. They not only facilitate the de novo synthesis of novel compounds, but also are able to produce metabolites, even in higher amounts than in the intact plants. Over recent decades, several attempts have been made to improve withanolide production by tissue culture (Ray and Jha 2001;Sharada et al. 2007;Dewir et al. 2010). Production of bioactive molecules by in-vitro liquid culturing techniques has gained considerable attention in recent years, and such methods are increasingly attractive alternatives to whole plant cultivation for production of high value phytochemicals (Pati et al. 2010;Gawde and Paratkar 2012).
4The pure compound of WS-3 is commercially obtained from the aerial parts of W. somnifera plants but the production is not sufficient for the current market demand. The chemical synthesis of withaferin A is comp...